Read patient and survivor stories about ovarian cancer, learn about risk factors, symptoms, and treatments, and more.
After breast cancer treatment and removal of a melanoma, Patty never imagined she would be diagnosed with ovarian cancer. Turns out she has the BRCA1 gene. Here’s her story.
Since her own experience with ovarian cancer, Joan has made it her mission to educate other women about this formidable disease.
In a study looking at the use of aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs), researchers found these meds can increase ovarian cancer survival.
In one of thousands of court cases around the United States involving talcum powder and cancer risk, a jury in St. Louis, Missouri, awarded $4.69 billion to 22 plaintiffs who claimed their ovarian cancer was caused by products manufactured by Johnson & Johnson.
Learn about a real-life experience with the gene mutation as well as your risk of cancer; cancer types if you have the mutation; and insurance coverage for any preventative treatment.
You thought finding out you had the BRCA1 or 2 gene mutation was tough – but now you have to tell your family members they might be at risk for it, too. Experts give advice on what to tell them when.
Dana Clark, M.S., L.C.G.C., at the Basser Center for BRCA at Penn Medicine, discusses when you’re at a high risk for BRCA gene mutations, what testing involves, and what misconceptions she commonly encounters.
A big one. "Jolie has been a blessing, and her stature as a celebrity speaking about this topic of gene mutations did more in one day with an op-ed than we could do in 10 years to raise awareness."
A genetic counselor shares how to manage the weight of discovering the genetic mutation that can predispose people to breast or ovarian cancer.
Elizabeth Millard is a freelance journalist specializing in health, wellness, fitness, and nutrition.
Bethany Kandel is a New York-based journalist, health writer, and author. She is also a breast cancer survivor.
A new screening test for endometrial and ovarian cancers detects genetic mutations in DNA from cervical fluid samples taken during routine Pap tests. Called PapSEEK and developed by researchers at the Johns Hopkins Kimmel Cancer Center in Baltimore, ...
New research to be presented at the American Association for Cancer Research meeting in April suggests that women with chronic chlamydia infections are twice as likely as women without the sexually transmitted infection to develop ovarian cancer. Res...
Researchers at the Roswell Park Comprehensive Cancer Center in Buffalo, New York have found a genetic mutation for ovarian cancer that can be passed from father to daughter. This genetic factor is also associated with an higher risk for prostate canc...